Coldstream Capital Management Inc. raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 27,382 shares of the healthcare conglomerate's stock after buying an additional 660 shares during the quarter. Coldstream Capital Management Inc.'s holdings in UnitedHealth Group were worth $13,852,000 at the end of the most recent reporting period.
A number of other hedge funds have also modified their holdings of UNH. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. Hurley Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $28,000. AlphaMark Advisors LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $30,000. Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group during the fourth quarter worth $30,000. Finally, Promus Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at $32,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Trading Up 0.3 %
Shares of UnitedHealth Group stock traded up $1.32 during midday trading on Wednesday, reaching $410.55. The company had a trading volume of 4,090,061 shares, compared to its average volume of 4,520,435. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a fifty-two week low of $401.28 and a fifty-two week high of $630.73. The stock has a fifty day moving average price of $499.59 and a 200 day moving average price of $532.08. The firm has a market cap of $373.69 billion, a PE ratio of 26.49, a P/E/G ratio of 1.37 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the previous year, the business posted $6.91 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 2.05%. UnitedHealth Group's dividend payout ratio is currently 35.18%.
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on the company. Wells Fargo & Company decreased their price target on UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Oppenheimer cut their price target on shares of UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating for the company in a research note on Monday, April 21st. KeyCorp dropped their target price on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Barclays lowered their price target on UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Finally, Erste Group Bank upgraded UnitedHealth Group to a "strong-buy" rating in a research note on Wednesday, April 16th. Three analysts have rated the stock with a hold rating, nineteen have given a buy rating and three have given a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Buy" and a consensus price target of $596.86.
Check Out Our Latest Research Report on UNH
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.